albuterol

An MDA-supported open-label trial found the asthma drug benefited 17 of 18 people with either of two forms of congenital myasthenic syndrome

posted on November 9, 2011 - 2:56pm
Researchers have found that the drug albuterol appears to be beneficial in two forms of congenital myasthenic syndrome (CMS) — CMS related to mutations in the collagen Q (colQ) gene and CMS related to mutations in the DOK7 gene.
posted on September 1, 2008 - 9:32am
QUEST Vol. 15, No. 5
This article includes items about: myotonic dystrophy type 1, myotonic dystrophy type 2, spinal muscular atrophy, spinal-bulbar muscular atrophy